Drug Type Monoclonal antibody |
Synonyms |
Target |
Action agonists |
Mechanism DR5 agonists(Tumor necrosis factor receptor superfamily member 10B agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | China | 25 Jul 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | China | 25 Jul 2018 | |
Solid tumor | Discovery | China | 25 Jul 2018 |